Email not displaying correctly? View it in your browser.

September 2018

Patient Care

New guideline recommends starting colon cancer screening at age 45
In an announcement published in late May, the American Cancer Society released new a guideline recommending that regular screening for colorectal cancer should begin at age 45 for adults at average risk.

FDA approves tofacitinib for use in adults with moderate to severe ulcerative colitis

Tofacitinib, a Janus kinase (JAK) inhibitor, is the first oral medication approved for chronic use in this indication.

Diagnosis and management of small bowel bleeding remains a challenging problem
While advances in endoscopic and radiologic testing have enabled gastroenterologists to successfully navigate difficult small bowel anatomy, detect mucosal lesions and perform therapy, several important issues require consideration.


Review of pancreatic cancer screening in high-risk individuals uses meta-analysis to estimate pooled detection and mortality rates for high-risk lesions
Because pancreatic cancer and precursor lesions detected early are potentially curable with surgery, there is growing interest in evaluating whether screening of high-risk individuals is effective.

See all Gastroenterology and Hepatology Clinical Trials at Mayo Clinic

Back to Top


Mayo Clinic Pancreatic and Hepato-Biliary Cancer Symposium 2018
Oct. 26-27, 2018, in Scottsdale, Ariz.
This course provides an update on the latest treatment options for patients with hepato-biliary and pancreatic cancers. A multidisciplinary focus on early diagnosis and treatment considerations includes surgery and new pharmacological agents, and how to incorporate them into clinical practice.

6th Annual Mayo Clinic Esophageal Diseases Course 2018
Nov. 30-Dec. 1, 2018, in Phoenix
This course showcases exciting advancements including high-resolution manometry, FLIP topography, impedance monitoring, new techniques in endoscopic detection and treatment of Barrett's esophagus, insights into the evolving approach to eosinophilic esophagitis, and updated management strategies for rumination.

Mayo Clinic Gastroenterology and Hepatology 2019
Feb. 21-24, 2019, in Scottsdale, Ariz.
This course updates providers practicing in gastroenterology and hepatology about new approaches to the diagnosis and management of gastrointestinal and liver diseases. Topics include gastroenterology, inflammatory bowel disease, colorectal neoplasia, esophageal disease, motility, nutrition, pancreaticobiliary disorders, endoscopy and hepatology.

Mayo Clinic Gastrointestinal Cancers 2019 Current and Emerging Strategies in Multidisciplinary Care
March 14-16, 2019, in San Diego
This course includes case-based and didactic presentations from Mayo Clinic staff and other international experts in the treatment of the whole spectrum of gastrointestinal cancers, including esophageal, gastric, hepatocellular, pancreatic, small bowel, bile duct, anal and colorectal, and gallbladder.

See all Gastroenterology Continuous Professional Development courses

Consults & Referrals

Connect With Us

Facebook iconTwitter iconYoutube icon

Receive real-time news and thought-leading insight

Back to Top

Mayo Clinic
13400 E. Shea Blvd.
Scottsdale, AZ 85259

4500 San Pablo Road
Jacksonville, FL 32224

200 First St. SW
Rochester, MN 55905